Maarten Dewilde

563 total citations
23 papers, 276 citations indexed

About

Maarten Dewilde is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Maarten Dewilde has authored 23 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Cancer Research. Recurrent topics in Maarten Dewilde's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Protease and Inhibitor Mechanisms (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Maarten Dewilde is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Protease and Inhibitor Mechanisms (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Maarten Dewilde collaborates with scholars based in Belgium, United Kingdom and United States. Maarten Dewilde's co-authors include Bart De Strooper, Tom Jaspers, Yessica Wouters, Paul Declerck, Laura Rué, Sergei V. Strelkov, Lutgarde Serneels, Griet Compernolle, Lucía Chávez‐Gutiérrez and Anja Rabijns and has published in prestigious journals such as Journal of Biological Chemistry, Nature Neuroscience and Brain.

In The Last Decade

Maarten Dewilde

20 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maarten Dewilde Belgium 11 151 78 46 44 39 23 276
Y. Joy Yu Zuchero United States 3 160 1.1× 117 1.5× 102 2.2× 12 0.3× 78 2.0× 4 387
Martin Siegemund Germany 9 228 1.5× 76 1.0× 137 3.0× 35 0.8× 34 0.9× 14 387
Ninh Doan United States 12 237 1.6× 31 0.4× 41 0.9× 59 1.3× 9 0.2× 20 413
Emmanuel Dornier United Kingdom 10 301 2.0× 28 0.4× 43 0.9× 115 2.6× 7 0.2× 11 481
Patrick Kilgannon United States 9 145 1.0× 37 0.5× 137 3.0× 23 0.5× 33 0.8× 14 375
Lisa Seipold Germany 6 132 0.9× 25 0.3× 22 0.5× 29 0.7× 23 0.6× 8 230
Ute Ipe Germany 9 261 1.7× 13 0.2× 135 2.9× 41 0.9× 50 1.3× 10 461
Mikkel R. Holst Denmark 12 242 1.6× 25 0.3× 24 0.5× 11 0.3× 42 1.1× 19 385
David Chodniewicz United States 7 246 1.6× 15 0.2× 109 2.4× 36 0.8× 11 0.3× 8 459
Yogita Kanan United States 13 299 2.0× 85 1.1× 28 0.6× 28 0.6× 7 0.2× 29 472

Countries citing papers authored by Maarten Dewilde

Since Specialization
Citations

This map shows the geographic impact of Maarten Dewilde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten Dewilde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten Dewilde more than expected).

Fields of papers citing papers by Maarten Dewilde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten Dewilde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten Dewilde. The network helps show where Maarten Dewilde may publish in the future.

Co-authorship network of co-authors of Maarten Dewilde

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten Dewilde. A scholar is included among the top collaborators of Maarten Dewilde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten Dewilde. Maarten Dewilde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albertini, Giulia, An Snellinx, Suresh Poovathingal, et al.. (2025). The Alzheimer’s therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia. Nature Neuroscience. 29(1). 100–110.
2.
3.
Jaspers, Tom, Christopher Cawthorne, Guy Bormans, et al.. (2025). Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein. Fluids and Barriers of the CNS. 22(1). 11–11. 4 indexed citations
4.
Bevan, Ryan J., et al.. (2025). Brain-penetrant anti-C7 therapy reduces neurodegeneration and microgliosis in an Alzheimer’s mouse model. Immunobiology. 230(4). 153000–153000.
5.
Zelek, Wioleta M., et al.. (2024). Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer’s disease mouse model. Brain. 148(3). 941–954. 10 indexed citations
6.
Geukens, Nick, et al.. (2023). Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice. Pharmaceutics. 15(4). 1160–1160. 2 indexed citations
7.
Rué, Laura, Tom Jaspers, Sam Noppen, et al.. (2023). Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics. Pharmaceutics. 15(6). 1748–1748. 14 indexed citations
8.
Serneels, Lutgarde, Rajeshwar Narlawar, Laura Pérez‐Benito, et al.. (2023). Selective inhibitors of the PSEN1–gamma-secretase complex. Journal of Biological Chemistry. 299(6). 104794–104794. 10 indexed citations
9.
Wouters, Yessica, Tom Jaspers, Laura Rué, et al.. (2022). VHHs as tools for therapeutic protein delivery to the central nervous system. Fluids and Barriers of the CNS. 19(1). 79–79. 26 indexed citations
10.
Hollevoet, Kevin, Debby Thomas, Griet Compernolle, et al.. (2022). Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model. Frontiers in Oncology. 12. 1017612–1017612. 7 indexed citations
11.
Wouters, Yessica, Tom Jaspers, Dimitri De Bundel, et al.. (2021). Applicability of cerebral open flow microperfusion and microdialysis to quantify a brain-penetrating nanobody in mice. Analytica Chimica Acta. 1178. 338803–338803. 11 indexed citations
12.
Wouters, Yessica, Tom Jaspers, Bart De Strooper, & Maarten Dewilde. (2020). Identification and in vivo characterization of a brain-penetrating nanobody. Fluids and Barriers of the CNS. 17(1). 62–62. 53 indexed citations
13.
Vlaeminck, Yannick De, Robin Maximilian Awad, Maarten Dewilde, et al.. (2020). Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development. Cancers. 12(12). 3582–3582. 26 indexed citations
14.
Rué, Laura, Bart Roucourt, Mieke Timmers, et al.. (2017). Identification and characterization of Nanobodies targeting the EphA4 receptor. Journal of Biological Chemistry. 292(27). 11452–11465. 25 indexed citations
15.
Veugelen, Sarah, Maarten Dewilde, Bart De Strooper, & Lucía Chávez‐Gutiérrez. (2016). Screening and Characterization Strategies for Nanobodies Targeting Membrane Proteins. Methods in enzymology on CD-ROM/Methods in enzymology. 584. 59–97. 10 indexed citations
16.
Dewilde, Maarten, Griet Compernolle, Jeppe Buur Madsen, et al.. (2010). Subtle structural differences between human and mouse PAI-1 reveal the basis for biochemical differences. Journal of Structural Biology. 171(1). 95–101. 16 indexed citations
17.
Dewilde, Maarten, Sergei V. Strelkov, Anja Rabijns, & Paul Declerck. (2008). High quality structure of cleaved PAI-1-stab. Journal of Structural Biology. 165(2). 126–132. 14 indexed citations
18.
Armas, Héctor Novoa de, et al.. (2007). Study of Recombinant Antibody Fragments and PAI-1 Complexes Combining Protein-Protein Docking and Results from Site-Directed Mutagenesis. Structure. 15(9). 1105–1116. 8 indexed citations
19.
Armas, Héctor Novoa de, et al.. (2007). Study of Recombinant Antibody Fragments and PAI-1 Complexes Combining Protein-Protein Docking and Results from Site-Directed Mutagenesis. Structure. 15(10). 1339–1339. 1 indexed citations
20.
Taeye, Bart De, et al.. (2003). Immobilization of the Distal Hinge in the Labile Serpin Plasminogen Activator Inhibitor 1. Journal of Biological Chemistry. 278(26). 23899–23905. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y. Joy Yu Zuchero Breakdown of academic impact, for papers by Martin Siegemund Breakdown of academic impact, for papers by Ninh Doan Breakdown of academic impact, for papers by Emmanuel Dornier Breakdown of academic impact, for papers by Patrick Kilgannon Breakdown of academic impact, for papers by Lisa Seipold Breakdown of academic impact, for papers by Ute Ipe Breakdown of academic impact, for papers by Mikkel R. Holst Breakdown of academic impact, for papers by David Chodniewicz Breakdown of academic impact, for papers by Yogita Kanan
Rankless by CCL
2026